In a near future shaped by precision medicine, cardiovascular care is being redefined by molecular targeting and adaptive therapies. One of the most pressing discussions among researchers and healthcare planners revolves around atherosclerosis drugs market inhibitors, especially as conventional lipid lowering approaches begin to show limitations in complex patient profiles. The challenge is no...
SkillClick